Israel took strong early steps against Covid-19, but now the virus is resurging and some say the country reopened too soon
After early success, Israel has seen a resurgence in infections and is now trying to figure out a plan against the virus.
Related Articles
Exclusive: China’s WuXi AppTec shared US client’s data with Beijing, US intelligence officials told senators
U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec had transferred U.S. intellectual property…
Biden Courts Caregivers, Pledging to Expand Support if He Is Re-elected
The president called for 12 weeks of paid family or medical leave, large investments in preschool for 4-year-olds and the extension of a child tax…
Grow Therapy Raises $88M Sequoia Capital-Led Series C to Advance Effective Mental Healthcare
/PRNewswire/ — Grow Therapy, a provider-centric mental health technology company improving access to high-quality mental healthcare, today announced the…
6 Strategic Concepts That Set High-Performing Companies Apart
Strategic concepts come in and out of fashion as the needs and dynamics of the marketplace change. Research and analysis of today’s landscape identifies six…
The case for paying ranchers to raise trees instead of cattle | Patrick Brown and Michael Eisen
Reducing cattle populations and restoring native ecoystems is our best chance to tackle global heating. Here’s one way to do it
Commercializing AI in Healthcare: The Jobs to be Done | Andreessen Horowitz
Building specialist AIs to perform healthcare tasks offers the most challenging technical problems in the field today, as well as the greatest opportunity for impact.
A dying child, a mother’s love and the drug that changed medicine
Hundreds of thousands of children are born each year with fatal neurodegenerative diseases. A gene therapy breakthrough offers hope of not just a treatment, but…
A dying child, a mother’s love and the drug that changed medicine
Hundreds of thousands of children are born each year with fatal neurodegenerative diseases. A gene therapy breakthrough offers hope of not just a treatment, but…
AI-powered Cherish Health has raised $26 million and is set to raise a $30 million Series B — and hasn’t grabbed a single dollar from VCs. Here’s why.
Home health startup Cherish Health raised $26 million without touching venture funding.
Age longevity clinic Modern Age shutters business
On Friday, age longevity company Modern Age announced the closure of its business after failing to secure adequate outside capital.